dronabinol has been researched along with pilocarpine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Miczek, KA | 2 |
| Digregorio, J; Nagle, B; Piraino, A; Tomassone, BM | 1 |
| Hopkins, GA | 1 |
| ten Ham, M; van Bijsterveld, OP; van Loenen, AC | 1 |
| Egashira, N; Fujii, M; Fujiwara, M; Hirosawa, N; Iwasaki, K; Matsumoto, Y; Mishima, K | 1 |
| Fratta, W; Goldberg, SR; Scherma, M; Solinas, M; Tanda, G; Wertheim, CE | 1 |
2 review(s) available for dronabinol and pilocarpine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Drug treatment of glaucoma.
Topics: Acetazolamide; Administration, Topical; Adrenergic beta-Antagonists; Bromocriptine; Clonidine; Dronabinol; Epinephrine; Glaucoma; Humans; Labetalol; Miotics; Nadolol; Parasympathomimetics; Pilocarpine; Propanolamines; Sympathomimetics; Timolol | 1984 |
8 other study(ies) available for dronabinol and pilocarpine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A behavioral analysis of aggressive behaviors induced and modulated by delta9-tetrahydrocannabinol, pilocarpine, d-amphetamine and l-dopa [proceedings].
Topics: Aggression; Animals; Behavior, Animal; Dextroamphetamine; Dominance-Subordination; Dronabinol; Humans; Levodopa; Pilocarpine; Rats | 1977 |
Mouse-killing and motor activity: effects of chronic delta9-tetrahydrocannabinol and pilocarpine.
Topics: Aggression; Animals; Cannabis; Crowding; Dose-Response Relationship, Drug; Dronabinol; Drug Tolerance; Humans; Male; Mice; Motor Activity; Pilocarpine; Posture; Rats | 1976 |
The influence of delta9-tetrahydrocannabinol on pilocarpine-induced parotid secretions of the rat.
Topics: Amylases; Animals; Blood Pressure; Calcium; Dronabinol; Heart Rate; Male; Parotid Gland; Pilocarpine; Potassium; Rats; Saliva; Sodium; Time Factors | 1976 |
The effect of hypotensive drugs on the intraocular pressure after waterloading in rabbits.
Topics: Acetazolamide; Animals; Antihypertensive Agents; Dronabinol; Epinephrine; Intraocular Pressure; Isoproterenol; Physostigmine; Pilocarpine; Rabbits; Time Factors; Timolol; Water | 1981 |
Characteristics of learning and memory impairment induced by delta9-tetrahydrocannabinol in rats.
Topics: Animals; Avoidance Learning; Discrimination Learning; Dronabinol; Hallucinogens; Injections, Intraventricular; Learning Disabilities; Maze Learning; Memory Disorders; Memory, Short-Term; Muscarinic Agonists; Muscarinic Antagonists; Pilocarpine; Piperidines; Pyrazoles; Rats; Rimonabant; Scopolamine | 2001 |
Nicotinic facilitation of delta9-tetrahydrocannabinol discrimination involves endogenous anandamide.
Topics: Animals; Arachidonic Acids; Discrimination, Psychological; Dose-Response Relationship, Drug; Dronabinol; Drug Synergism; Endocannabinoids; Enzyme Inhibitors; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Mecamylamine; Muscarinic Agonists; Muscarinic Antagonists; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Pilocarpine; Polyunsaturated Alkamides; Rats; Rats, Sprague-Dawley; Reaction Time; Receptor, Cannabinoid, CB1; Receptors, Muscarinic; Receptors, Nicotinic; Reinforcement, Psychology; Scopolamine | 2007 |